ARTA
BSTG

A.R.T. Advisors’s Biostage, Inc. Common Stock BSTG Stock Holding History

A.R.T. Advisors’s Portfolio BSTG Stock Details BSTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-10,910
Closed -$12K – 1486
2016
Q2 		$12K Buy
+10,910
New +$17.6K ﹤0.01% 1310
2015
Q3 		– Sell
-21,833
Closed -$31K – 1779
2015
Q2 		$31K Buy
+21,833
New +$53.5K ﹤0.01% 1424
2015
Q1 		– Sell
-11,440
Closed -$36K – 1858
2014
Q4 		$36K Buy
+11,440
New +$56.7K ﹤0.01% 1360

Other funds holding BSTG

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TSP
Tappan Street Partners Chicago, Illinois $35.7M AUM 42.68% 1-Year Est. Return
WIC
Woodmont Investment Counsel Nashville, Tennessee $1.62B AUM 18.92% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

A.R.T. Advisors's BSTG Position: Q3 2016 in Review

A.R.T. Advisors sold out of Biostage, Inc. Common Stock (BSTG) in Q3 2016, closing a stake of 10,910 shares — an estimated $12K sold.

A.R.T. Advisors first reported a position in BSTG in Q4 2014 and held it in 3 quarters. The position peaked at $36K in Q4 2014. 26 funds tracked by Wall St. Rank hold BSTG as of Q3 2016.

  • A.R.T. Advisors reported no remaining Biostage, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • A.R.T. Advisors sold 10,910 Biostage, Inc. Common Stock shares in Q3 2016, an estimated $12K.
  • A.R.T. Advisors first reported a position in Biostage, Inc. Common Stock in Q4 2014 and held it in 3 quarters.
  • A.R.T. Advisors's Biostage, Inc. Common Stock position peaked at $36K in Q4 2014.
  • 26 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q3 2016.

Based on A.R.T. Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.